Table 1 Demographic, laboratory and clinical data of acute leukemia patients (AML and ALL) and control group

 Male

18 (60%)

12 (40%)

15 (50%)

 Female

12 (40%)

18 (60%)

15 (50%)

 Median

30.0

27.0

31.0

 Range

17.0-70.0

19.30-55.0

18.0-65.0

 TLC ×10³/μL

111.5±138.06^a

137.36 ±190.21^a

7.11±1. 72 ^a

 Hemoglobin g/dl

7 ±1.7 ^a

8.4 ±1.6 ^a

11.7 ±1.0^a

 Platelet ×10³/μL

75.2±81.3 ^a

59.3±62.1 ^a

306.3 ±78.5 ^a

 Blasts^b

62.6±29.3 ^a

76.5±26.7^a

NA^d

 Hepatomegaly

15 (50%)

16 (53.3%)

NA^d

 Splenomegaly

13 (43.3%)

17 (56.7%)

NA^d

 Lymphadenopathy

7 (23.3%)

26 (86.7%)

NA^d

 CR^c

16 (53.3%)

19 (63.3%)

NA^d

 NCR^{c & e}

14 (46.6%)

9 (30%)

NA^d